Insider Stock Trading History of Oliviero James F Iii


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Oliviero James F Iii since year 2005. The trader's CIK number is 1434718. At the time of this reporting, Oliviero James F Iii is the Chief Financial Officer of Keryx Biopharmaceuticals Inc . (stock ticker symbol KERX). See this page for all insider trading activities at Keryx Biopharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Oliviero James F Iii since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-07-06 KERX Keryx Biopharmaceuticals Inc Sale 1,943 9.61 18,672
2015-05-12 KERX Keryx Biopharmaceuticals Inc Option Ex 41,611 2.66 110,477
2015-04-06 KERX Keryx Biopharmaceuticals Inc Sale 1,878 11.68 21,935
2015-01-05 KERX Keryx Biopharmaceuticals Inc Sale 5,604 13.79 77,279
2014-12-10 KERX Keryx Biopharmaceuticals Inc Sale 25,000 15.69 392,250
2014-12-10 KERX Keryx Biopharmaceuticals Inc Option Ex 25,000 11.22 280,500
2014-10-03 KERX Keryx Biopharmaceuticals Inc Sale 2,694 16.14 43,481
2014-09-08 KERX Keryx Biopharmaceuticals Inc Sale 144,237 15.88 2,290,483
2014-07-07 KERX Keryx Biopharmaceuticals Inc Sale 2,054 15.75 32,350
2014-04-03 KERX Keryx Biopharmaceuticals Inc Sale 2,087 16.46 34,352
2014-03-21 KERX Keryx Biopharmaceuticals Inc Sale 13,444 15.11 203,138
2014-03-20 KERX Keryx Biopharmaceuticals Inc Sale 125,000 15.04 1,880,000
2014-03-19 KERX Keryx Biopharmaceuticals Inc Sale 154,039 15.23 2,346,013
2014-03-19 KERX Keryx Biopharmaceuticals Inc Option Ex 104,039 3.30 343,016
2014-01-03 KERX Keryx Biopharmaceuticals Inc Sale 6,309 12.57 79,304
2013-12-30 KERX Keryx Biopharmaceuticals Inc Sale 79,500 12.63 1,004,085
2013-12-27 KERX Keryx Biopharmaceuticals Inc Sale 30,000 12.68 380,400
2013-12-30 KERX Keryx Biopharmaceuticals Inc Option Ex 30,000 4.59 137,700
2013-10-03 KERX Keryx Biopharmaceuticals Inc Sale 1,475 10.25 15,118
2013-07-05 KERX Keryx Biopharmaceuticals Inc Sale 1,438 7.95 11,432
2013-05-13 KERX Keryx Biopharmaceuticals Inc Sale 29,363 8.34 244,887
2013-04-05 KERX Keryx Biopharmaceuticals Inc Sale 1,484 6.93 10,284
2013-01-04 KERX Keryx Biopharmaceuticals Inc Sale 10,859 2.74 29,753
2012-10-03 KERX Keryx Biopharmaceuticals Inc Sale 4,973 2.72 13,526
2012-07-03 KERX Keryx Biopharmaceuticals Inc Sale 4,559 1.99 9,072
2012-04-05 KERX Keryx Biopharmaceuticals Inc Sale 5,458 1.60 8,738
2012-01-03 KERX Keryx Biopharmaceuticals Inc Sale 7,190 2.62 18,873
2011-10-03 KERX Keryx Biopharmaceuticals Inc Sale 6,105 2.82 17,191
2011-07-05 KERX Keryx Biopharmaceuticals Inc Sale 4,611 4.80 22,132
2011-06-06 KERX Keryx Biopharmaceuticals Inc Sale 47,231 4.99 235,682
2011-04-05 KERX Keryx Biopharmaceuticals Inc Sale 4,490 5.10 22,899
2011-01-03 KERX Keryx Biopharmaceuticals Inc Sale 14,064 4.67 65,678
2010-12-03 KERX Keryx Biopharmaceuticals Inc Sale 24,150 5.06 122,198
2010-12-02 KERX Keryx Biopharmaceuticals Inc Sale 107,623 5.01 539,191
2010-12-06 KERX Keryx Biopharmaceuticals Inc Sale 3,600 5.00 18,000
2010-10-04 KERX Keryx Biopharmaceuticals Inc Sale 1,209 4.58 5,537
2010-08-20 KERX Keryx Biopharmaceuticals Inc Sale 10,000 3.84 38,400
2010-07-06 KERX Keryx Biopharmaceuticals Inc Sale 1,213 3.35 4,063
2010-06-08 KERX Keryx Biopharmaceuticals Inc Sale 41,497 3.96 164,535
2010-05-12 KERX Keryx Biopharmaceuticals Inc Sale 60,000 6.26 375,600
2010-05-12 KERX Keryx Biopharmaceuticals Inc Option Ex 31,667 2.14 67,767
2010-04-05 KERX Keryx Biopharmaceuticals Inc Sale 899 3.36 3,020
2010-01-05 KERX Keryx Biopharmaceuticals Inc Sale 22,981 2.60 59,773
2009-06-23 KERX Keryx Biopharmaceuticals Inc Buy 2,750 .90 2,472
2009-05-22 KERX Keryx Biopharmaceuticals Inc Buy 25,000 .40 9,925

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Oliviero James F Iii (Chief Financial Officer of Keryx Biopharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.